JPRN-UMIN000038699
Recruiting
未知
Development of biomarkers for psychiatric disorders (schizophrenia, mood disorders, dementia) by cerebrospinal fluid - Development of biomarkers for psychiatric disorders (schizophrenia, mood disorders, dementia) by cerebrospinal fluid
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Saga University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclude high\-risk patients such as Bleeding tendency, heparin use, anesthesia allergies,increased brain pressure, or patients judged to be inappropriate by a doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Investigation of biomarkers of multiple psychiatric disorders based on the analyses of large-scale MRI dataAutism spectrum disorder Schizophrenia Depression Attention deficit hyperactivity disorderJPRN-UMIN000016134Medical Institute of Developmental Disabilities Research, Showa University690
Completed
Not Applicable
research on biomarker for atypical depressioatypical depressionJPRN-UMIN000037616Hirosaki University Hospital department of anesthesiology100
Completed
Not Applicable
Development of biomarkers for phenotype classification toward precision medicine in obstructive sleep apneaDiseases of the nervous systemKCT0004885Chonnam National University Hospital2,000
Not yet recruiting
Not Applicable
Symptom-based research in psychiatric disorderspsychiatric disordersJPRN-UMIN000037843Kyoto University, Graduate School of Medicine, Medical Innovation Center400
Recruiting
Not Applicable
Symptom-based research in psychiatric disorderspsychiatric disordersJPRN-UMIN000034020Kyoto University400